Certificate Course in Medical Information
- Description
- Curriculum
- Reviews
-
1Medical Information
Medical Information deals with the collection, handling and dissemination of information on medicines, and their safe and correct use. The med info department acts as the link between the Marketing Authorisation Holder and the patient, caretaker or healthcare professional (HCP).
-
2Translating the Evidence: The Medical Information Workflow
-
3The First Line of Defense: Medical Information and Global Drug Safety
-
4The Silent Strategist: Medical Information’s Strategic Value
-
5UK Guidelines for the Pharmaceutical Industry Medical Information Departments
For educational purposes only
Ref: https://pipaonline.org/wp-content/uploads/2022/02/Pipa-MI-Guideline-Document_Jan-2022_final.pdf
-
6Global Medical Information – Quiz
-
7Reading Materials
Student Guide: The Role and Practice of Medical Information in the Pharmaceutical Industry
1. Introduction to Medical Information (MI)
Medical Information (MI) serves as the strategic epicenter for scientific evidence dissemination within the broader Medical Affairs (MA) organization. Far from being a mere help desk, MI is a critical conduit that informs healthcare decision-making by providing trusted, clinical, and scientific product information. This function bridges the gap between the pharmaceutical manufacturer and those who seek scientific clarity—whether through interactions with field sales or through independent research.
In its customer-facing capacity, the Medical Information department acts as the primary “face” of the manufacturer. By managing scientific inquiries with clinical precision, MI professionals directly facilitate the safe and effective use of marketed products across the global healthcare landscape.
2. Core Objectives of a "Best-in-Class" MI Organization
To elevate the practice of MI from a functional task to a strategic asset, the industry relies on a joint collaboration between the Medical Affairs Professional Society (MAPS), Medical Information Leaders in Europe (MILE), and phactMI. These organizations have established a standardized framework to achieve the following:
- Establish a blueprint for building a structured, high-performing Medical Information organization.
- Create global consistency and harmonization across the pharmaceutical industry.
- Identify and articulate MI value for both internal and external stakeholders.
- Elevate the practice of Medical Information to ensure it remains a cornerstone of Medical Affairs.
3. Understanding the MI Customer Base
MI professionals must tailor their communication to a diverse array of stakeholders. Understanding these categories is essential for maintaining professional and regulatory compliance.
Customer Category
Specific Examples
Healthcare Professionals (HCPs)
Physicians and Pharmacists.
Allied Health Professionals (AHPs)
Nurses and other practitioners, including Nurse Practitioners (NPs) and Physician Assistants (PAs).
Life Science Professionals
Research Scientists (PhDs) and Non-HCP Formulary Decision Makers.
Other External Groups
Patients, Caregivers, and Payers.
4. The Value of Medical Information
The value proposition of an MI department is twofold, supporting the external medical community and the internal corporate strategy.
External Value: Scientific Exchange and Trust
- Aids HCP Education: Supports clinical decision-making by providing accurate, fair-balanced data to ensure optimal treatment outcomes.
- Safe Harbor for Scientific Exchange: MI acts as the legally protected "safe harbor" for responding to unsolicited requests for off-label information. This allows for the dissemination of scientific data that commercial or sales teams are prohibited from discussing.
- Patient Support: Serves as a reliable resource for patients and caregivers, which can significantly improve treatment adherence and safety.
- Formulary and Guideline Support: Prepares complex submissions for AMCP dossiers, clinical pathway documents, and guideline bodies like the NCCN.
Internal Value: Cross-Functional Synergy
MI is a hub of internal intelligence, partnering with a wide array of departments:
- Strategic Planning: Collaborates with Clinical Development, Publication Planning, and Marketing to prepare for successful product launches.
- Compliance & Accuracy: Reviews promotional and medical materials to ensure every claim is scientifically grounded.
- Operational Support: Provides critical data to Finance, Manufacturing, and Business Technology to align supply and digital infrastructure with medical needs.
- Customer Insights: Captures and shares trends from customer inquiries to help shape future medical strategies and commercial campaigns.
5. Regulatory Frameworks and the Code of Practice
MI professionals operate within a strict ethical and legal framework to maintain the distinction between scientific exchange and promotion.
The phactMI Code of Practice
When responding to HCP requests, MI leaders adhere to three foundational pillars:
- Clinical & Pharmaceutical Expertise: Professionals possess relevant healthcare degrees and specialized training in Medical Information Science.
- Scientific Balance: All written responses must be evidence-based, accurate, truthful, non-misleading, and strictly non-promotional.
- Quality Standards: Content must undergo a rigorous review and approval process, with regular updates to ensure currency.
Global Regulatory Distinctions
Navigating the regulatory landscape requires an understanding of regional nuances:
- United States: Guided by the FDA Guidance for Industry, which specifically addresses responding to unsolicited requests for off-label information and the distribution of scientific publications on unapproved uses.
- Europe: Operations are governed by EMA overarching directives; however, students must recognize that specific interpretations of what constitutes "scientific exchange" vary significantly by individual country.
6. Integration with Pharmacovigilance and Quality
MI is an essential intake point for information regarding the safety profile and physical integrity of a product.
- Pharmacovigilance (PV) Support: MI professionals are trained to identify and process Adverse Events (AEs), supporting the Drug Safety and Labeling departments.
- Product Integrity: MI serves as a primary source for identifying Product Quality Complaints (PQCs), ensuring manufacturing or packaging issues are escalated to Quality Assurance (QA).
7. Operational Skills and Technology
The modern MI professional must combine deep clinical knowledge with technical proficiency.
- Professional Expertise: Mastery of Medical Information Science, literature review methodologies, and regulatory compliance.
- Core Deliverables:
- Scientific Response Documents (SRDs) / Standard Response Letters (SRLs): Evidence-based, peer-reviewed answers to common inquiries.
- Frequently Asked Questions (FAQs): Structured data for rapid retrieval.
- Innovation: The industry is currently integrating Artificial Intelligence (AI) and Natural Language Processing (NLP) to optimize search capabilities and delivery channels while maintaining GDPR and data privacy standards.
8. Essential Abbreviations for Students
This table provides the pedagogical foundation for navigating industry-specific terminology.
Abbreviation
Full Term
Context/Category
AE
Adverse Event
Safety / Pharmacovigilance
AHP
Allied Health Professional
Customer Stakeholder
AHRQ
Agency for Healthcare Research and Quality
Regulatory / Health Outcomes
AI
Artificial Intelligence
Technology / Innovation
DERP
Drug Effectiveness Review Project
Health Outcomes
EBM
Evidence-based Medicine
Clinical Practice
EU / EMA
European Union / European Medicines Agency
Regulatory Body
FAQ
Frequently Asked Question
MI Deliverable
FDA
Food and Drug Administration (US)
Regulatory Body
GDPR
General Data Privacy Regulation
Legal / Data Privacy
HCP
Healthcare Professional
Customer Stakeholder
ICER
Institute for Clinical and Economic Review
Health Outcomes / Payers
KPI
Key Performance Indicator
Operational Metrics
MA
Medical Affairs
Departmental Organization
MI
Medical Information
Departmental Function
MIR
Medical Information Request
Operational Task
MSL
Medical Science Liaison
Field Medical Stakeholder
NLP
Natural Language Processing
Technology / Innovation
NPI
National Provider Identifier
Regulatory / US Operations
PI
Prescribing Information
Regulatory / Labeling
PQC
Product Quality Complaint
Quality / Manufacturing
QA
Quality Assurance
Departmental Organization
SOP
Standard Operating Procedure
Regulatory / Operational
SRD / SRL
Scientific Response Document / Letter
MI Deliverable
9. Conclusion: The Blueprint for Success
As you have seen, Medical Information is not merely a supportive role but a strategic pillar within the pharmaceutical industry. By adhering to a global blueprint for excellence, MI fulfill legal and ethical obligations while serving as the vital link between clinical data and patient care. Mastering these elements ensures that you contribute to a culture of transparency, scientific integrity, and ultimately, improved health outcomes.
-
8ABPI CODE OF PRACTICE FOR THE PHARMACEUTICAL INDUSTRY
For educational purposes only
Ref: https://www.pmcpa.org.uk/media/r0anf5ya/2024-abpi-code.pdf
-
9Essential Elements of a “Best-in-Class” Medical Information Organization
For educational purposes only
Ref: https://www.mile-association.org/wp-content/uploads/2023/06/MedInfo-SG-2022-12-1.pdf
